Menu

Interactive Infographic: State Laws for Medical Aid-in-Dying

In six states and the District of Columbia, terminally ill patients can get a perscription for a life-ending drug, and several additional states are considering legalizing the practice.

Aug 16, 2017
Catherine Offord

Medical aid-in-dying—a physician’s prescription for a lethal dose of a drug to end a patient’s life—is legal for terminally ill patients in six states and the District of Columbia. A further 30 states have been considering legislation on medical aid-in-dying during this year’s legislative session, according to advocacy group Death with Dignity. Euthanasia—the practice of assisting in someone else’s death directly, for example, by physician-administered lethal injection—is currently not legal anywhere in the United States. (Click the labeled states for more information about their practices.)

DEVELOPED BY KARL PAWLOWICZ

Since we developed this map, three additional states have proposed legislation regarding medical aid-in-dying: Oklahoma, New Jersey, and Rhode Island.

See world map for an overview of practices by country.

Correction (August 29): This map has been updated to correctly identify the light orange–shaded states as those considering legislation, while the medium orange states have no proposed legislation. The Scientist regrets the error.

July/August 2019

On Target

Researchers strive to make individualized medicine a reality

Marketplace

Sponsored Product Updates

DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 Software
DNASTAR® announced the release of Lasergene 16 today, which includes a broad range of improvements in for analysis of DNA, RNA and protein sequence data, as well as new advancements for predicting and analyzing protein structures. 
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences Partners with Curio Genomics for Analysis of IWGSC Wheat Exome
Arbor Biosciences, a division of Chiral Technologies, Inc and worldwide leader in next generation sequencing (NGS) target enrichment, announces a partnership with Curio Genomics for bioinformatics analysis of the wheat genome.
IDT and Washington University join forces to increase access to the latest NGS technologies
IDT and Washington University join forces to increase access to the latest NGS technologies
As part of its commitment to advocate for the genomics age, Integrated DNA Technologies (IDT) aims to lower the barriers to access the latest NGS technologies.
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Launches Bio-Plex Pro Human Immunotherapy Panel 20-plex Multiplex Assay, a targeted tool for researching signaling networks in Immunotherapy Research
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) July 15, 2019 announced the launch of its Bio-Plex Pro Human Immunotherapy Panel 20-plex, a multiplex immunoassay that offers a targeted approach for Immunotherapy Research.